BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
See all
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
See all
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
Monoclonal Antibody Productivity
Single Use
A Fully Single-Use Downstream Process for Monoclonal Antibodies
A Fully Single-Use Downstream Process for Monoclonal Antibodies
by
Shunsuke Shiina,
Neha Saxena
and 1 more
Apr 17, 2024
Artificial intelligence
Information Technology
Using Artificial Intelligence for Monoclonal Antibody Discovery
Using Artificial Intelligence for Monoclonal Antibody Discovery
by
William Whitford
Apr 17, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
Cell-Line
Cell Line Development
Cell-Line Discussions at BPI West 2024
Cell-Line Discussions at BPI West 2024
by
Cheryl Scott
May 10, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
See all
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX
Emerging Therapeutics
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
by
Suranjana Sen
Apr 17, 2024
Characterization methodologies
Emerging Therapeutics
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
by
Sanjib Banerjee,
Rajiv Bharadwaj
Apr 17, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Global Markets
US looks to 2032 as cut-off from Chinese biomanufacturing reliance
US looks to 2032 as cut-off from Chinese biomanufacturing reliance
by
Dan Stanton
May 13, 2024
3 Min Read
thumbnail
Deal Making
ExacellGene and Cytovance partner to advance CHO and HEK cells
ExacellGene and Cytovance partner to advance CHO and HEK cells
by
Shreeyashi Ojha
May 13, 2024
2 Min Read
Home
Analytical
Product Characterization
Product Characterization
Advancements in Characterizing Therapeutic Protein Higher-Order Structure
Laboratory Equipment
Advancements in Characterizing Therapeutic Protein Higher-Order Structure
Advancements in Characterizing Therapeutic Protein Higher-Order Structure
by
Mike Bogan,
Henry Benner
Apr 18, 2017
Enabling Faster Workflows with Protein Purification Technologies: Improvements in Chromatography and Electrophoresis
Product Characterization
Enabling Faster Workflows with Protein Purification Technologies: Improvements in Chromatography and Electrophoresis
Enabling Faster Workflows with Protein Purification Technologies: Improvements in Chromatography and Electrophoresis
by
Gunjan Choudhary,
Laura Moriarty
Apr 13, 2017
Evolving Bioassay Strategies for Therapeutic Antibodies: Essential Information for Proving Biosimilarity
Biosimilars
Evolving Bioassay Strategies for Therapeutic Antibodies: Essential Information for Proving Biosimilarity
Evolving Bioassay Strategies for Therapeutic Antibodies: Essential Information for Proving Biosimilarity
by
Ulrike Herbrand
Apr 12, 2017
Biological Characterization Using Protein Crystal Measurements
Product Characterization
Biological Characterization Using Protein Crystal Measurements
Biological Characterization Using Protein Crystal Measurements
by
William Wittbold,
Kuba Tatarkiewicz
Mar 20, 2017
A Statistical Approach to Assess and Justify Potential Product Specifications
QA/QC
A Statistical Approach to Assess and Justify Potential Product Specifications
A Statistical Approach to Assess and Justify Potential Product Specifications
by
Todd Coffey, PhD,
Keith M. Bower
Feb 13, 2017
Biosimilar Therapeutic Monoclonal Antibodies: Gaps in Science Limit Development of an Industry Standard for Their Regulatory Approval, Part 2
Biosimilars
Biosimilar Therapeutic Monoclonal Antibodies: Gaps in Science Limit Development of an Industry Standard for Their Regulatory Approval, Part 2
Biosimilar Therapeutic Monoclonal Antibodies: Gaps in Science Limit Development of an Industry Standard for Their Regulatory Approval, Part 2
by
Simran J. Kaur,
Darryl Sampey
and 3 more
Nov 14, 2016
Product Characterization
Mass Spectrometric Conjugate Characterization: Process Qualification of Recombinant Protein–Hapten Conjugation
Mass Spectrometric Conjugate Characterization: Process Qualification of Recombinant Protein–Hapten Conjugation
Nov 14, 2016
+2
by
Miao-Fang Lin,
Margo Wilson
and 2 more
QA/QC
Investigation of Foreign-Particle Contamination: Practical Application of FT-IR, Raman, and SEM-EDS Technologies
Investigation of Foreign-Particle Contamination: Practical Application of FT-IR, Raman, and SEM-EDS Technologies
Sep 15, 2016
+2
by
Junghwa Kim,
Derek Schildt
and 2 more
CMC Forums
Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control
Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control
Sep 15, 2016
+8
by
Zahra Shahrokh,
Dieter Schmalzing
and 8 more
Formulation
Osmolality Measurements for High-Concentration Protein–Polymer Solutions: Variation Based on Working Principles of Osmometers
Osmolality Measurements for High-Concentration Protein–Polymer Solutions: Variation Based on Working Principles of Osmometers
Jun 15, 2016
+3
by
Erinc Sahin,
Rajesh Gandhi
and 3 more
Product Characterization
Enhanced Biosimilar Product Characterization: A Case Study Using Raman Spectroscopy Combined with Dynamic Light Scattering
Enhanced Biosimilar Product Characterization: A Case Study Using Raman Spectroscopy Combined with Dynamic Light Scattering
Jun 15, 2016
+3
by
Wei Qi,
Stacy Kenyon
and 3 more
Product Characterization
Benefits of Using Tetradetector SEC to Characterize Membrane Proteins
Benefits of Using Tetradetector SEC to Characterize Membrane Proteins
Apr 12, 2016
by
Larry Miercke,
Stephen Ball
Product Characterization
Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations
Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations
Feb 4, 2016
+9
by
Nadine Ritter,
Reb Russell
and 9 more
Biosimilars
Primary and Higher-Order Structural Characterization Strategy for Biosimilarity Assessment
Primary and Higher-Order Structural Characterization Strategy for Biosimilarity Assessment
Dec 16, 2015
by
Fiona M. Greer
Biosimilars
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles, Challenges, and Opportunities
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles, Challenges, and Opportunities
Nov 17, 2015
+2
by
Anthony Ridgway, PhD,
Nadine Ritter
and 2 more
Cell Therapies
Mapping Success for Commercial Cell Therapy Manufacturing
Mapping Success for Commercial Cell Therapy Manufacturing
Oct 15, 2015
+2
by
Bob Preti,
Ann M. Daus
and 2 more